This Viewpoint discusses important questions about how to efficiently screen for hepatitis B virus (HBV) for those at risk of HBV reactivation.
This study pools patient cohorts from randomized and nonrandomized studies to investigate associations between pembrolizumab therapy and tumor response among patients with advanced melanoma with and without prior ipilimumab therapy.
This Editorial discusses the optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma.
Moulton and coauthors report results from a randomized clinical trial on the effect of positron emission tomography (PET) before liver resection on surgical management for colorectal adenocarcinoma metastases.
This case series involving children and young adults with cancer whose genomic sequencing results were the basis for clinical case recommendations charaterizes the number of clinically actionable findings and resulting patient outcomes.